GHRL and metabolic syndrome: As the ghrelin axis also plays a role in the progression of a number of endocrine-related cancers [5, 32–34], including prostate cancer [5, 43], we hypothesised that UAG has beneficial effects in advanced prostate cancer associated with metabolic syndrome.